Patents Assigned to TransMedics, Inc.
-
Patent number: 11963526Abstract: Apparatus for perfusion of multiple types of organs include base unit configured to removably couple with a perfusion module for perfusing an organ. The base unit has conduits for connecting a source of a perfusate to the organ to circulate the perfusate through the organ; first and second pumps coupled to the conduits for driving circulation of the perfusate in the conduits; and a controller configured and connected for controlling the first and second pumps to regulate the circulation of the perfusate through the organ. The controller is operable to control the first and second pumps to perfuse the organ in accordance with organ specific perfusion parameters. The organ specific perfusions parameters are selected based on the type of the organ, and may be selected by an operator for at least two organ types selected from the group of heart, liver, kidney and lung.Type: GrantFiled: July 9, 2021Date of Patent: April 23, 2024Assignee: TRANSMEDICS, INC.Inventor: Darren Freed
-
Patent number: 11944088Abstract: The invention generally relates to systems, methods, and devices for ex vivo organ care. More particularly, in various embodiments, the invention relates to caring for a liver ex vivo at physiologic or near-physiologic conditions.Type: GrantFiled: October 25, 2021Date of Patent: April 2, 2024Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Tamer I. Khayal, Ahmed Elbetanony, Jeff Barnes, Greg Ritchie, Richard Bringham, Mark Anderson, John Sullivan
-
Patent number: 11917991Abstract: Electrode systems have been developed for use in perfusion systems to measure the electrical activity of an explanted heart and to provide defibrillation energy as necessary. The perfusion systems maintain the heart in a beating state at, or near, normal physiological conditions; circulating oxygenated, nutrient enriched perfusion fluid to the heart at or near physiological temperature, pressure and flow rate. These systems include a pair of electrodes that are placed epicardially on the right atrium and left ventricle of the explanted heart, as well as an electrode placed in the aortic blood path.Type: GrantFiled: May 21, 2019Date of Patent: March 5, 2024Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Ahmed Elbetanony, Richard Bringham, Robert Havener, Vincent Lambert, II, Burt Ochs
-
Patent number: 11903381Abstract: The disclosure generally relates to a system for perfusing an ex-vivo liver including a pump configured to pump a perfusion fluid through a perfusion circuit, the pump in fluid communication with a hepatic artery interface and a portal vein interface; an oxygenator; a heater; an inferior vena cava interface in fluid communication with an inferior vena cava of the ex-vivo liver; and a reservoir configured to receive the perfusion fluid from the inferior vena cava of the ex-vivo liver and store a volume of fluid.Type: GrantFiled: April 18, 2022Date of Patent: February 20, 2024Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Tamer I. Khayal, Ahmed Elbetanony, Jeff Barnes, Greg Ritchie, Richard Bringham, Mark Anderson, John Sullivan
-
Patent number: 11856944Abstract: An ex-vivo lung solution for machine perfusion of donor lungs on OCS. The solution may be mixed with whole blood or packed red blood cells to form the OCS lung perfusion solution.Type: GrantFiled: July 20, 2022Date of Patent: January 2, 2024Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Ihab Abdel Fattah, Paul Lezberg, Tamer I. Khayal, Robert Havener, Anas Abdelazim
-
Publication number: 20230413805Abstract: The disclosure, in various embodiments, provides systems, methods, and solutions for perfusing an organ. The present application describes illustrative methods for perfusing an ex-vivo organ in a functioning state under physiological or near physiological conditions, including receiving an ex-vivo organ in an organ care system, the ex-vivo organ coupled to a perfusion circuit, infusing a solution into the system, combining the solution with a perfusion fluid to create a mixed solution, pumping the mixed solution to the ex-vivo organ, and receiving the mixed solution from the ex-vivo organ.Type: ApplicationFiled: September 1, 2023Publication date: December 28, 2023Applicant: TransMedics, Inc.Inventors: Waleed H. HASSANEIN, Tamer I. KHAYAL, Paul LEZBERG
-
Patent number: 11844345Abstract: The invention, in various embodiments, provides systems, methods and solutions for perfusing an organ.Type: GrantFiled: August 2, 2018Date of Patent: December 19, 2023Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Tamer I. Khayal, Paul Lezberg
-
Patent number: 11723357Abstract: The disclosure provides, in various embodiments, systems, devices and methods relating to ex-vivo organ care. In certain embodiments, the disclosure relates to maintaining an organ ex-vivo at near physiologic conditions. In certain embodiments, the disclosure relates to testing properties of an ex-vivo heart or an organ care system, adjusting a property of the organ care system in response to certain results of the testing, and re-testing the ex-vivo heart or the organ care system. In certain embodiments, the disclosure relates to synchronizing at least one cycle of a pumping of a perfusion fluid with a state of the ex-vivo heart.Type: GrantFiled: November 18, 2021Date of Patent: August 15, 2023Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Richard Bringham, Giovanni Cecere, Tamer I. Khayal, Ronald Taylor, Jr., Hossam Algamil
-
Patent number: 11570985Abstract: The invention provides, in various embodiments, systems, devices and methods relating to ex-vivo organ care. In certain embodiments, the invention relates to maintaining an organ ex-vivo at near-physiologic conditions. The present application describes a method for using lactate measurement in the arterial and the venous blood lines of the Organ Care System Heart perfusion device to evaluate the: 1) The overall perfusion status of an isolated heart and 2) The metabolic status of an isolated heart and 3) the overall vascular patency of an isolated donor heart. This aspect of the present invention uses the property of myocardial cell's unique ability to produce/generate lactate when they are starved for oxygen and metabolize/utilize lactate for energy production when they are well perfused with oxygen.Type: GrantFiled: June 30, 2020Date of Patent: February 7, 2023Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Tamer I. Khayal, Ahmed Elbetanony, Paul Lezberg, Giovanni Cecere, Dennis Sousa, Elizabeth Hansen Bulger
-
Patent number: 11191263Abstract: An organ care system including a blood product heater that includes a heater inlet, a channel, and a heater outlet, wherein the heater inlet includes an inside cross-sectional area and an inside cross-sectional shape configured to flow a blood product into the blood product heater, wherein the heater outlet comprises an inside cross-sectional area and an inside cross-sectional shape configured to flow the blood product out of the blood product heater, and wherein the channel extends between the heater inlet and the heater outlet and is formed between a first flow channel plate and a second flow channel plate; and a first heater thermally coupled to the first flow channel plate configured to heat the first flow channel plate; and a pump configured to circulate a heated blood product to an organ being preserved.Type: GrantFiled: April 26, 2019Date of Patent: December 7, 2021Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Richard Bringham, Giovanni Cecere, Tamer I. Khayal, Ronald Taylor, Jr., Hossam Algamil
-
Patent number: 11154050Abstract: The invention generally relates to systems, methods, and devices for ex vivo organ care. More particularly, in various embodiments, the invention relates to caring for a liver ex vivo at physiologic or near-physiologic conditions.Type: GrantFiled: September 13, 2018Date of Patent: October 26, 2021Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Tamer I. Khayal, Ahmed Elbetanony, Jeff Barnes, Greg Ritchie, Richard Bringham, Mark Anderson, John Sullivan
-
Patent number: 11122795Abstract: The invention provides, in various embodiments, devices and methods relating to ex-vivo organ care. In certain embodiments, the invention relates to aortic cannulas for use in perfusion systems to return perfusate to the heart or delivering perfusate from the heart while the organ is sustained ex vivo at physiologic or near-physiologic conditions.Type: GrantFiled: December 21, 2018Date of Patent: September 21, 2021Assignee: TRANSMEDICS, INC.Inventors: Greg Ritchie, Vincent Lambert, II, Richard Bringham, John Sullivan, Waleed H. Hassanein
-
Patent number: 10750738Abstract: Methods and systems of maintaining, evaluating, and providing therapy to a lung ex vivo. The methods and systems involve positioning the lung in an ex vivo perfusion circuit; circulating a perfusion fluid through the lung, the fluid entering the lung through a pulmonary artery interface and leaving the lung through a left atrial interface; and ventilating the lung by flowing a ventilation gas through a tracheal interface. Maintaining the lung for extended periods involves causing the lung to rebreath a captive volume of air, and reaching an equilibrium state between the perfusion fluid and the ventilation gas. Evaluating the gas exchange capability of the lung involves deoxygenating the perfusion fluid and measuring a time taken to reoxygenate the perfusion fluid by ventilating the lung with an oxygenation gas.Type: GrantFiled: April 8, 2008Date of Patent: August 25, 2020Assignee: TRANSMEDICS, INC.Inventors: Robert Fishman, Robert Havener, Ihab Abdel Fattah, Anas Abdelazim, Scott Newell, Thomas H. Bishop, Tamer Khayal, Stanley Kyi, Ron Taylor, Doug Harriott, Matthew De Remer, Paul Murray, John Sullivan, Mark Anderson, Richard Bringham, Michael Van Driel, Waleed Hassanein
-
Patent number: 10736314Abstract: The invention provides, in various embodiments, systems, devices and methods relating to ex-vivo organ care. In certain embodiments, the invention relates to maintaining an organ ex-vivo at near-physiologic conditions. The present application describes a method for using lactate measurement in the arterial and the venous blood lines of the Organ Care System Heart perfusion device to evaluate the: 1) The overall perfusion status of an isolated heart and 2) The metabolic status of an isolated heart and 3) the overall vascular patency of an isolated donor heart. This aspect of the present invention uses the property of myocardial cell's unique ability to produce/generate lactate when they are starved for oxygen and metabolize/utilize lactate for energy production when they are well perfused with oxygen.Type: GrantFiled: April 26, 2019Date of Patent: August 11, 2020Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Tamer I. Khayal, Ahmed Elbetanony, Paul Lezberg, Giovanni Cecere, Dennis Sousa, Elizabeth (Hansen) Bulger
-
Patent number: 10327443Abstract: Electrode systems have been developed for use in perfusion systems to measure the electrical activity of an explanted heart and to provide defibrillation energy as necessary. The perfusion systems maintain the heart in a heating state at, or near, normal physiological conditions; circulating oxygenated, nutrient enriched perfusion fluid to the heart at or near physiological temperature, pressure and flow rate. These systems include a pair of electrodes that are placed epicardially on the right atrium and left ventricle of the explanted heart, as well as an electrode placed in the aortic blood path.Type: GrantFiled: July 11, 2016Date of Patent: June 25, 2019Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Ahmed Elbetanony, Richard Bringham, Robert Havener, Vincent Lambert, II, Burt Ochs
-
Patent number: 10321676Abstract: The invention provides, in various embodiments, systems, devices and methods relating to ex-vivo organ care. In certain embodiments, the invention relates to maintaining an organ ex-vivo at near-physiologic conditions. The present application describes a method for using lactate measurement in the arterial and the venous blood lines of the Organ Care System Heart perfusion device to evaluate the: 1) The overall perfusion status of an isolated heart and 2) The metabolic status of an isolated heart and 3) the overall vascular patency of an isolated donor heart. This aspect of the present invention uses the property of myocardial cell's unique ability to produce/generate lactate when they are starved for oxygen and metabolize/utilize lactate for energy production when they are well perfused with oxygen.Type: GrantFiled: December 29, 2017Date of Patent: June 18, 2019Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Tamer I. Khayal, Ahmed Elbetanony, Paul Lezberg, Giovanni Cecere, Dennis Sousa, Elizabeth Hansen Bulger
-
Patent number: 10314303Abstract: The invention provides, in various embodiments, systems, devices and methods relating to ex-vivo organ care. In certain embodiments, the invention relates to maintaining an organ ex-vivo at near-physiologic conditions.Type: GrantFiled: November 12, 2015Date of Patent: June 11, 2019Assignee: TRANSMEDICS, INC.Inventors: Waleed H. Hassanein, Richard Bringham, Giovanni Cecere, Tamer I. Khayal, Ronald Taylor, Jr., Hossam Algamil
-
Publication number: 20190110466Abstract: The invention provides, in various embodiments, devices and methods relating to ex-vivo organ care. In certain embodiments, the invention relates to aortic cannulas for use in perfusion systems to return perfusate to the heart or delivering perfusate from the heart while the organ is sustained ex vivo at physiologic or near-physiologic conditions.Type: ApplicationFiled: December 21, 2018Publication date: April 18, 2019Applicant: TransMedics, Inc.Inventors: Greg RITCHIE, Vincent LAMBERT, II, Richard BRINGHAM, John SULLIVAN, Waleed H. HASSANEIN
-
Patent number: 10194655Abstract: The invention provides, in various embodiments, devices and methods relating to ex-vivo organ care. In certain embodiments, the invention relates to aortic cannulas for use in perfusion systems to return perfusate to the heart or delivering perfusate from the heart while the organ is sustained ex vivo at physiologic or near-physiologic conditions.Type: GrantFiled: September 7, 2016Date of Patent: February 5, 2019Assignee: TRANSMEDICS, INC.Inventors: Greg Ritchie, Vincent Lambert, II, Richard Bringham, John Sullivan, Waleed H. Hassanein
-
Publication number: 20190021308Abstract: The invention generally relates to systems, methods, and devices for ex vivo organ care. More particularly, in various embodiments, the invention relates to caring for a liver ex vivo at physiologic or near-physiologic conditions.Type: ApplicationFiled: September 13, 2018Publication date: January 24, 2019Applicant: TransMedics, Inc.Inventors: Waleed H. HASSANEIN, Tamer I. KHAYAL, Ahmed ELBETANONY, Jeff BARNES, Greg RITCHIE, Richard BRINGHAM, Mark ANDERSON, John SULLIVAN